17.05.2014 Views

PEBC Report - Programa de Epigenética y Biología del Cáncer

PEBC Report - Programa de Epigenética y Biología del Cáncer

PEBC Report - Programa de Epigenética y Biología del Cáncer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SPEAKERS BIOGRAPHY AND ABSTRACT<br />

Peter W Andrews<br />

Peter Andrews, PhD, obtain a BSc in<br />

Biochemistry from the University of<br />

Leeds in 1971, and a D. Phil. in<br />

Genetics from the University of Oxford<br />

in 1975. Following postdoctoral<br />

research at the Institut Pasteur in Paris<br />

and the Sloan Kettering Institute in<br />

New York, he was a research scientist<br />

on the staff of the Wistar Institute of<br />

Anatomy and Biology in Phila<strong>de</strong>lphia<br />

from 1978 to 1992. In 1992 he was appointed to the Arthur<br />

Jackson Chair of Biomedical Research in the University of<br />

Sheffield, where he is currently co-director of the Centre for<br />

Stem Cell Biology. His research focuses on the biology of<br />

pluripotent human stem cells. Among his current activities<br />

he co-ordinates the International stem Cell Initiative, which is<br />

focused upon characterising standard markers and culture<br />

conditions for human ES cells. He is also the co-ordinator of<br />

ESTOOLS, a European Integrated Project of 21 partners<br />

un<strong>de</strong>r the sixth framework program.<br />

The Centre for Stem Cell Biology<br />

and Department of Biomedical Science,<br />

The University of Sheffield, UK<br />

Population Dynamics of Human ES Cell<br />

Cultures: Self-Renewal, Adaptation and Cancer<br />

of the population as a whole, without taking account of the<br />

consequent heterogeneity of such cultures. Further, a<br />

propensity for differentiation provi<strong>de</strong>s a basis for selective<br />

pressures that may lead to the appearance of variant ES<br />

cells that exhibit an increased probability of self renewal<br />

over differentiation, or cell <strong>de</strong>ath through apoptosis.<br />

In<strong>de</strong>ed human ES cell lines do tend to accumulate nonrandom<br />

genetic changes on prolonged culture. These<br />

genetic changes inclu<strong>de</strong> amplifications of chromosomes<br />

12, 17 and X similar to those seen in embryonal carcinoma<br />

(EC) cells, the stem cells of teratocarcinomas and the<br />

malignant counterparts of ES cells. Thus the progressive<br />

culture adaptation of human ES cells in culture provi<strong>de</strong>s a<br />

unique mo<strong>de</strong>l that may be pertinent to the progression of<br />

stem cell based cancers.<br />

Accumulating evi<strong>de</strong>nce suggests that the ‘stem cell compartment’<br />

in both ES and other stem cells, including cancer<br />

stem cells, may be composed of distinct substates.<br />

Another aspect of culture adaption of human ES cells is<br />

that it alters the population dynamics of ES cultures, particularly<br />

affecting the behavior of substates within the<br />

stem cell compartment. Un<strong>de</strong>rstanding the nature of<br />

these substates and their interactions may provi<strong>de</strong><br />

insights into the mechanisms that control self renewal,<br />

commitment to differentiation and lineage selection of ES<br />

and, ultimately iPS cells. Inevitably these same mechanisms<br />

may also play a role in cancer progression.<br />

A key feature of pluripotent stem cells is their ability to proliferate<br />

in<strong>de</strong>finitely while maintaining an ability to differentiate<br />

into all somatic cell types. Such proliferation is known as<br />

‘self-renewal’. However, these cells may also differentiate<br />

spontaneously, or in response to specific cues. When they<br />

divi<strong>de</strong>, stem cells must choose between self renewal and<br />

commitment to differentiation. Further, if they commit to differentiate<br />

they must choose between different lineages. An<br />

un<strong>de</strong>rstanding of the molecular mechanisms that control<br />

these <strong>de</strong>cision processes un<strong>de</strong>rlies any potential use of<br />

human embryonic stem (ES) cells, or iPS cells, whether in<br />

regenerative medicine or in other areas such as drug discovery,<br />

toxicology or disease mo<strong>de</strong>ling.<br />

Some <strong>de</strong>gree of spontaneous differentiation is common in<br />

cultures of human ES cells. This can confuse studies of<br />

human ES cell behavior if assays are based on assessment<br />

Selected Publications<br />

Andrews, P.W. (2002). From teratocarcinomas to embryonic<br />

stem cells. Phil. Trans. R. Soc. Lond. B 357, 405-417.<br />

Baker, D.E.C., Harrison, N.J., Maltby, E., Smith, K., Moore,<br />

H.D., Shaw, P.J., Heath, P.R., Hol<strong>de</strong>n, H., Andrews, P.W.,<br />

(2007) Adaptation to culture of human embryonic stem cells<br />

and oncogenesis in vivo. Nature Biotechnology 25: 207 –<br />

215.<br />

Draper J.S. Smith, K., Gokhale, P.J., Moore, H.D., Maltby, E.,<br />

Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A.,<br />

Andrews, P.W. (2004) Karyotypic evolution of human<br />

Embryonic Stem (ES) cells in culture: recurrent gain of chromosomes<br />

17 (17q) and 12. Nat. Biotech. 22: 53-54<br />

Enver T, Soneji S, Joshi C, Iborra F, Orntoft T, Thykjaer T, Maltby<br />

E, Smith K, Abu Dawd R, Matin M, Gokhale P, Draper JS,<br />

Andrews, P.W. (2005) Cellular differentiation hierarchies in<br />

normal and culture adapted human embryonic stem cells.<br />

Human Mol Genet. 14: 1-12.<br />

13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!